Marine Natural Products as Models to Circumvent Multidrug Resistance

Solida Long1, Emília Sousa2,3, Anake Kijjoa4,5

  • 1Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto 4050-313, Portugal. up201502099@ff.up.pt.

Insights

Marine natural products can inhibit P-glycoprotein (P-gp), a key factor in multidrug resistance (MDR) to cancer drugs. Synthetic strategies enhance availability of these compounds, offering new models for developing MDR-inhibiting drug candidates.

Area of Science:

  • Marine natural products
  • Medicinal chemistry
  • Drug discovery

Background:

  • Multidrug resistance (MDR) is a major challenge in cancer therapy, often caused by P-glycoprotein (P-gp) efflux pumps.
  • Natural products offer a promising avenue for discovering MDR modulators, but supply limitations necessitate synthetic approaches.

Purpose of the Study:

  • To review marine natural products and their derivatives with P-gp inhibitory activity.
  • To highlight structure-activity relationships and synthetic pathways for promising compounds.

Main Methods:

  • Literature review of marine natural products with P-gp inhibitory activity.
  • Summary of established structure-activity relationships.
  • Presentation of synthetic pathways for key marine compounds and analogs.

Main Results:

  • Identified various marine natural product classes (alkaloids, sterols, polyketides, terpenoids, diketopiperazines, peptides) exhibiting P-gp inhibitory effects.
  • Detailed structure-activity relationships for these compounds.
  • Outlined synthetic strategies for producing potent MDR inhibitors.

Conclusions:

  • Marine natural products serve as valuable models for developing novel anticancer drugs that overcome MDR.
  • Further research into synthesis and activity can lead to new therapeutic agents targeting ABC transporters.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.2K